Dina Jacobs - Faculty Biosketch

Dina Jacobs, M.D.

Associate Professor of Neurology at the Hospital of the University of Pennsylvania

Clinical Director, Penn MS and Related Disorders Program , Perelman School of Medicine at the Hospital of the University of Pennsylvania

Director, Community Outreach and Network Development, Penn MS and Related Disorders Program , Perelman School of Medicine at the Hospital of the University of Pennsylvania

Neuroscience MS Disease Team Lead , Penn Medicine

Medical monitor , Penn Medicine Community Vaccine Clinics

Clinical Director, Center for Neuroinflammation and Experimental Therapeutics, Penn Medicine

Neurology Outpatient Director, HUP and PCAM, Penn Medicine

Director, Penn Women's Neurology Program , Penn Medicine

Department: Neurology

Contact information

Department of Neurology
Hospital of the University of Pennsylvania
3400 Spruce Street
3 West Gates Building
Philadelphia, PA 19104

Office: (215) 662-3647
Fax: (215) 349-5579

Education:
B.A. (Natural Science, Spanish)
University of Pennsylvania , 1990.
M.D.
University of Pennsylvania, 1996.

Post-Graduate Training
Intern, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, 1996-1997.
Resident, Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, 1997-2000.
Clinical Instructor, Divisions of Multiple Sclerosis and Neuro-Ophthalmology, Hospital of the University of Pennsylvania, Philadelphia, 2000-2002.
Fellow, Multiple Sclerosis, Hospital of the University of Pennsylvania, Philadelphia , 2000-2001.
Fellow, Neuro-Ophthalmology , Hospital of the University of Pennsylvania, Scheie Eye Institute, Philadelphia, 2001-2002.

Certifications
American Board of Psychiatry and Neurology , 2001.
American Board of Psychiatry and Neurology; Recertification, 2011.
American Board of Psychiatry and Neurology; Recertification, 2022.

Permanent link

> Perelman School of Medicine > Faculty > Details

Selected Publications

Kakara M, Martinak E, McCormick B, Morales KH, Bogner HR, Jacobs DA, Wolf Tuton L : The Bridging the Gaps program: Three Decades of Collaborative Service-Oriented Learning in the Health Professions. Academic Medicine 2023 in press.

Touil H, Li R, Zuroff L, Moore CS, Healy L, Cignarella F, Piccio L, Ludwin S, Prat A, Gommerman J, Bennett FC, Jacobs D, Benjamins JA, Lisak RP, Antel JP, Bar-Or A: Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis. EBioMedicine (Lancet Discovery Science) 11(96), Sep 2023.

Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson K, Kakara M, Zuroff L, Bennett J, von Budingen HC, Carruthers R, Edwards K, Fallis R, Giacomini P, Greenberg B, Hafler D, Ionete C, Kaunzner U, Lock C, Longbrake E, Pardo G, Piehl F, Weber M, Ziemssen T, Jacobs D, Gelfand J, Cross A, Cameron B, Musch B, Winger R, Jia X, Harp C, Herman A, Bar-Or A.: Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. PNAS 120(3): e2207291120, Jan 2023.

Bar-Or A, Jacobs D, Stelzig L, Kim E, Giardino M, Prieur L, Herman A, Craveiro L, Jones D, Arnold D, Reschly K, Kibiy A, Barry W, McNamara J: Randomized, blinded discontinuation trial of ocrelizumab in early relapsing multiple sclerosis: The Autoimmunity Centers of Excellence AMS05 Study. ECTRIMS, Milan, Italy 2023.

Graham EL, Bakkensen JB, Anderson A, Lancki N, Davidson A, Perez Giraldo G, Jungheim ES, Vanderhoff AC, Ostrem B, Mok-Lin E, Huang D, Bevan CJ, Jacobs D, Kaplan TB, Houtchens MK, and Bove R.: Inflammatory Activity after Diverse Fertility Treatments: A Multicenter Analysis in the Modern MS Treatment Era. Neurology: Neuroimmunology & Neuroinflammation 10(3), 2023.

Lancet Neurology Editorial Board: Towards equitable access to treatment for multiple sclerosis (Editorial on Committee Report from Multiple Sclerosis International Federation Essential Medicines Panel Recommendations for Essential Medicines for the World Health Organization). The Lancet Neurology 2023.

Anderson A, Rowles W, Poole S, Balan A, Bevan C, Brandstadter R, Ciplea A, Cooper J, Fabian M, Hale, T, Jacobs D, Kakara M, Krysko K, Longbrake E, Marcus J, Repovic P, Riley C, Romeo A, Rutatangwa A, West T, Hellwig K, LaHue S, Bove R.: Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions. Annals of Clinical and Translational Neurology doi: 10.1002/acn3.51893, 2023.

Anne Marie Radzik, Lilyana Amezcua, Annika Anderson, Serena Gilmore, Sophie Ahmad, Rachel Brandstadter, Michelle Fabian, Edith Graham, Sophia Hodgkinson, Lindsay Horton, Dina Jacobs, lana Katz Sand, Amit Kohli, Libby S. Levine, Monica McLemore, Annette Okai, Jasmin Patel, Shane Poole, Claire S. Riley, Sammita Satyanarayan, Lauren Tardo, Elizabeth Verter, Veronica Villacorta, Vanessa Zimmerman, Leah Zuroff, Mitzi Williams, Maria Houtchens, Riley Bove: Disparities by Race in Pregnancy Care and Clinical Outcomes in Women with MS: a Diverse, Multicenter Cohort American Academy of Neurology Annual Meeting, Boston, MA 2023.

Multiple Sclerosis International Federation Essential Medicines Panel: Multiple Sclerosis International Federation Essential Medicines List for World Heatlh Organization Special Populations: Pregnancy and Breastfeeding in MS in Low-Resource Settings. World Health Organization International 2023.

Multiple Sclerosis International Federation Essential Medicines Panel: Multiple Sclerosis International Federation Essential Medicines List for World Heatlh Organization Special Populations: Pregnancy and Breastfeeding in MS World Health Organization International 2023.